T1	Pharmacological_substance 20 30	Pyrethrins
N1000 	Reference T1 MeSH:D011722	Pyrethrins
T3	Pharmacological_substance 112 122	Pyrethrins
N1001 	Reference T3 MeSH:D011722	Pyrethrins
T4	Pharmacological_substance 311 321	Pyrethrins
N1002 	Reference T4 MeSH:D011722	Pyrethrins
T5	Pharmacological_substance 378 398	sodium Phenobarbital
N1003 	Reference T5 MeSH:D010634	sodium Phenobarbital
T10	Pharmacological_substance 624 637	Phenobarbital
N1004 	Reference T10 MeSH:D010634	Phenobarbital
T11	Pharmacological_substance 711 721	Pyrethrins
N1005 	Reference T11 MeSH:D011722	Pyrethrins
T12	Pharmacological_substance 726 739	Phenobarbital
N1006 	Reference T12 MeSH:D010634	Phenobarbital
T15	Pharmacological_substance 765 802	7-benzyloxy-4-trifluoromethylcoumarin
N1007 	Reference T15 MeSH:C419147	7-benzyloxy-4-trifluoromethylcoumarin
T23	Pharmacological_substance 895 905	Pyrethrins
N1008 	Reference T23 MeSH:D011722	Pyrethrins
T24	Pharmacological_substance 910 923	Phenobarbital
N1009 	Reference T24 MeSH:D010634	Phenobarbital
T28	Pharmacological_substance 1056 1069	Phenobarbital
N1010 	Reference T28 MeSH:D010634	Phenobarbital
T30	Pharmacological_substance 1083 1095	testosterone
N1011 	Reference T30 MeSH:D013739	testosterone
T35	Pharmacological_substance 1202 1212	Pyrethrins
N1012 	Reference T35 MeSH:D011722	Pyrethrins
T36	Pharmacological_substance 1217 1230	Phenobarbital
N1013 	Reference T36 MeSH:D010634	Phenobarbital
T37	Pharmacological_substance 1334 1344	Pyrethrins
N1014 	Reference T37 MeSH:D011722	Pyrethrins
T38	Pharmacological_substance 1434 1447	Phenobarbital
N1015 	Reference T38 MeSH:D010634	Phenobarbital
T48	Pharmacological_substance 1616 1626	Pyrethrins
N1016 	Reference T48 MeSH:D011722	Pyrethrins
T49	Pharmacological_substance 1628 1641	Phenobarbital
N1017 	Reference T49 MeSH:D010634	Phenobarbital
T50	Pharmacological_substance 1765 1778	Phenobarbital
N1018 	Reference T50 MeSH:D010634	Phenobarbital
T18	Disorder 131 162	liver and thyroid gland tumours
T45	Pharmacological_substance 340 377	rat liver and thyroid tumour promoter
T8	Pharmacological_substance 595 605	Pyrethrins
N1019 	Reference T8 MeSH:D011722	Pyrethrins
T52	Combination 322 326	with
T54	Combination 606 609	and
T55	Disorder 667 679	cytotoxicity
T56	Negation_cue 642 645	not
T66	Combination 722 725	and
T72	Pharmacological_substance 1041 1051	Pyrethrins
N1020 	Reference T72 MeSH:D011722	Pyrethrins
T81	Pharmacological_substance 1455 1465	Pyrethrins
N1021 	Reference T81 MeSH:D011722	Pyrethrins
T88	Pharmacological_substance 1646 1663	related compounds
T89	Subject 1731 1738	rodents
T90	Disorder 1687 1727	liver and thyroid gland tumour formation
T92	Subject 1822 1828	humans
T93	Negation_cue 1809 1812	not
T94	Speculation_cue 1779 1787	suggests
T95	Subject 166 170	rats
T9	Subject 496 521	female Sprague-Dawley rat
T96	Subject 526 554	human (both male and female)
T20	Pharmacological_substance 953 965	testosterone
N1022 	Reference T20 MeSH:D013739	testosterone
T27	Subject 1023 1028	human
T31	Subject 1370 1373	rat
T33	Speculation_cue 1664 1670	can be
T34	Subject 68 71	rat
T78	Subject 76 81	human
T80	Subject 447 450	rat
T97	Subject 455 460	human
T98	Subject 690 693	rat
T99	Subject 996 999	rat
T100	Subject 1563 1568	human
T101	Subject 1378 1383	human
